Recovery Act Funds Available for Sleep Researchers

Applications for a total of $1.5 billion in grants funded by the American Recovery and Reinvestment Act of 2009 are now available through the National Institutes of Health (NIH), including Challenge Grant funds allocated for the advancement of slee

Short Sleepers Increase Risk of High Blood Sugar by 4.5 Times

Sleeping less than 6 hours a night during the work week increases the risk of elevated levels of blood sugar by 4.5 times compared to those who sleep 6 to 8 hours, according to new research findings from the University at Buffalo. “Impaire

BRPT Launches “Life as an RPSGT”

This year the Board of Registered Polysomnographic Technologists (BRPT) celebrates the 30th anniversary of the RPSGT credential. As part of the celebration, the BRPT has added a special section to its Web site in honor of the work of RPSGTs across

FDA Rejects Silenor Insomnia Treatment

The US Food and Drug Administration (FDA) issued a Complete Response Letter to Somaxon Pharmaceuticals, San Diego, for the company’s New Drug Application (NDA) for its insomnia drug Silenor®  (doxepin). After review the FDA determine

CMS Posts Sleep Testing Final Coverage Policy

The Centers for Medicare and Medicaid Services (CMS) has released the final coverage decision for sleep testing for the diagnosis of obstructive sleep apnea (OSA). The final policy identifies the sleep tests that can be used by a beneficiary&rsq

Forest, Cypress Delay Launch of Fibromyalgia Drug

Last Updated: 2009-03-06 9:00:16 -0400 (Reuters Health) * Now see mid-2009 launch, delayed from March * Seek "minor" cosmetic change NEW YORK (Reuters) – Forest Laboratories Inc and Cypress Bioscience Inc said on Friday that they